Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,729,539
+$421,101 QoQ
Shares Held
10,847
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#1,713
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEACON FINANCIAL GROUP holds $17,924,673 across 8 Drug Manufacturers - General names. ABBV ranks #4 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,149 | $4,101,361 | |
| 2 | AMGN |
Amgen Inc
|
8,964 | $3,246,043 | |
| 3 | NVS |
Novartis AG
|
20,231 | $3,170,602 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,847 | $2,729,539 | |
| 5 | PFE |
Pfizer Inc
|
94,815 | $2,283,145 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,047 | $905,539 | |
| 7 | LLY |
ELI LILLY & Co
|
740 | $887,578 | |
| 8 | SNY |
Sanofi
|
14,085 | $600,866 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,729,539 | 10,847 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,308,438 | 10,614 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,424,507 | 10,611 | Shares | Sole | 2026-04-01 | |
| 2025-09-30 | $2,432,096 | 10,504 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,926,178 | 10,377 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,144,856 | 10,237 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,953,456 | 10,993 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,175,637 | 11,017 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,935,603 | 11,285 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,028,958 | 11,142 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,768,827 | 11,414 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $1,658,888 | 11,129 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,534,574 | 11,390 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,857,776 | 11,657 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $2,201,451 | 13,622 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,931,416 | 14,391 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,305,211 | 15,051 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,444,943 | 15,082 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $2,044,946 | 15,103 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $1,603,163 | 14,862 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,629,788 | 14,469 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,552,199 | 14,343 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $1,536,852 | 14,343 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,362,637 | 15,557 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,483,499 | 15,110 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,137,440 | 14,929 | Shares | Sole | 2020-06-29 | |
| No filing history on record for this holder in this stock. | ||||||